International Clinical Trial: Can Baseline Peripheral Blood Inflammatory Markers Predict Early Neurological Deterioration After Thrombolysis in Acute Ischemic Stroke Patients?

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132857) titled 'Can Baseline Peripheral Blood Inflammatory Markers Predict Early Neurological Deterioration After Thrombolysis in Acute Ischemic Stroke Patients?' on Sept. 18.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Beijing Tsinghua Changgung Hospital

Condition: Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-02

Target Sample Size: END group (case group):302;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341889

Pu...